3M Drug Delivery Systems announces the expansion of the pressurized metered dose inhaler (pMDI) fill line at its facility in Northridge, Calif., significantly extending the company’s manufacturing capability. The addition of the pressure fill line complements the existing state-of-the-art cold fill line in the facility and enhances 3M Drug Delivery Systems’ inhalation manufacturing services for customers. With the expansion, 3M Northridge can manufacture new and marketed pressure filled pMDI products for its customers on a global scale, solidifying 3M Drug Delivery Systems’ “start-to-finish” reputation as a single-source provider for the development and commercialization of the pMDI. Additionally, the company has established a Qualified Person (QP) release route to Europe.
“This expansion reflects our continued growth,” said Louise Righton, global divisional marketing manager for 3M Drug Delivery Systems. “Customers are responding enthusiastically to our manufacturing expertise, which capitalizes on Lean Six Sigma methodology to drive efficiency.”
Since creating the first metered dose inhaler 50 years ago, 3M Drug Delivery Systems has continued to lead in the development of new technologies and manufacturing services for inhaled drug delivery. 3M Drug Delivery Systems currently has four strategically located pMDI filling sites and the company has experience manufacturing products for distribution in more than 60 countries worldwide.
In the early stages of product development, 3M Drug Delivery Systems offers formulation screening and optimization for both solutions and suspensions, including particle engineering to improve dosing performance. The company also offers an array of pMDI components such as valves and canisters that can be customized to fit customers’ needs, as well as actuators and dose counters, which improve the patient experience.
Date: April 26, 2012
Source: 3M Drug Delivery Systems
Filed Under: Drug Discovery